Evigrade
Moderate

Acetylsalicylic acid × meloxicam

Antiplatelet agents (low dose) / NSAIDs (analgesic dose)×NSAID, COX-2 preferential, oxicam derivative

Mechanism

Meloxicam is preferentially COX-2 selective and weakly displaces aspirin from COX-1. Additive GI bleeding risk persists from the ulcerogenic effect of both drugs.

Symptoms

Gum bleeding, epistaxis, bruising without trauma, black or tarry stools. Severe cases: GI bleeding.

Management

Aspirin's cardioprotective effect is preserved better than with ibuprofen/naproxen. PPI cover with pantoprazole is mandatory in chronic meloxicam therapy. Alternative analgesic: paracetamol or celecoxib.

Sources

All interactions